沈 武典

Medicine & Life Sciences

1. Antidepressive Agents 100%
2. Bipolar Disorder 92%
3. Taiwan 89%
4. Antipsychotic Agents 85%
5. Bibliometrics 66%
6. Psychiatry 62%
7. Major Depressive Disorder 62%
8. Prescriptions 60%
9. Olanzapine 52%
10. Lithium 47%
11. Depression 46%
12. Clozapine 41%
13. Schizophrenia 40%
14. Citalopram 38%
15. General Hospitals 30%
16. Aripiprazole 28%
17. Risperidone 27%
18. Therapeutics 26%
19. Pharmaceutical Preparations 26%
20. Paroxetine 26%
21. Mental Disorders 25%
22. Psychiatric Hospitals 25%
23. Singapore 25%
24. Post-Traumatic Stress Disorders 23%
25. Health Expenditures 23%
26. Genetic Polymorphisms 22%
27. Omega-3 Fatty Acids 21%
28. Alcoholism 20%
29. Quetiapine Fumarate 20%
30. Unsaturated Fatty Acids 20%
31. Complementary Therapies 19%
32. Attention Deficit Disorder with Hyperactivity 19%
33. Serum 19%
34. Pharmacology 19%
35. Asenapine 19%
36. Depressive Disorder 19%
37. Lurasidone Hydrochloride 18%
38. Inpatients 18%
39. Psychotic Disorders 17%
40. Benzodiazepines 17%
41. Demography 17%
42. Publications 17%
43. Dendritic Cells 17%
44. Wakefulness-Promoting Agents 17%
45. Health 16%
46. Interleukin-10 16%
47. ziprasidone 16%
48. Pityriasis Rosea 16%
49. Cytochrome P-450 CYP2D6 16%